IL6 and neoplasm: In vivo results showed that after 20 days of gavage administration of SNLP‐1 (4 mg/kg/day), macrophages in the LLC tumor model mice significantly down‐regulated NO, TNF‐α, and IL‐6, reducing tumor volume and weight.